Serum monoclonal component in chronic lymphocytic leukemia: baseline correlations and prognostic impact

• Pablo Mozas,
• Juan A. Pineyroa,
• Ferran Nadeu,
• Laura Magnano,
• Andrea Rivero,
• Alfredo Rivas-Delgado,
• Alex Bataller,
• Aleix Fabregat,
• Eva Gine,
• Tycho Baumann,
• Neus Villamor,
• Juan Ignacio Arostegui,
• Marta Aymerich,
• Armando Lopez-Guillermo,
• Elias Campo,
• Julio Delgado

Affiliations

Pablo Mozas

Department of Hematology, Hospital Clínic, Barcelona

Juan A. Pineyroa

Department of Hematology, Hospital Clínic, Barcelona

Ferran Nadeu

Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid

Laura Magnano

Department of Hematology, Hospital Clínic, Barcelona, Spain; Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona

Andrea Rivero

Department of Hematology, Hospital Clínic, Barcelona

Alfredo Rivas-Delgado

Department of Hematology, Hospital Clínic, Barcelona

Alex Bataller

Department of Hematology, Hospital Clínic, Barcelona

Aleix Fabregat

Department of Biochemistry and Molecular Biology, Hospital Clínic, Barcelona

Eva Gine

Department of Hematology, Hospital Clínic, Barcelona, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid

Tycho Baumann

Department of Hematology, Hospital Clínic, Barcelona

Neus Villamor

Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain; Hematopathology Unit, Department of Pathology, Hospital Clínic, Barcelona

Juan Ignacio Arostegui

Department of Immunology, Hospital Clínic, Barcelona

Marta Aymerich

Hematopathology Unit, Department of Pathology, Hospital Clínic, Barcelona

Armando Lopez-Guillermo

Department of Hematology, Hospital Clínic, Barcelona, Spain; Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain; Universitat de Barcelona

Elias Campo

Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain; Hematopathology Unit, Department of Pathology, Hospital Clínic, Barcelona, Spain; Universitat de Barcelona

Julio Delgado

Department of Hematology, Hospital Clínic, Barcelona, Spain; Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid